(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

COMBINAÇÃO DE POZIOTINIBE COM AGENTE CITOTÓXICO E/OU OUTRO AGENTE DIRECIONADO MOLECULARMENTE E USO DO MESMO

ArquivadaInvention PatentPCT · US2019038971

Application data

Number

112020026367

Type

Invention Patent

Filing

06/25/2019

Publication

03/30/2021

PCT

US2019038971

Progress at the INPI

  1. Filing06/25/19
  2. Publication03/30/21
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 06/25/2019 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 12/20/2022. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

SPECTRUM PHARMACEUTICALS, INC.

CA

See this company's full portfolio

Inventors

G. R. (pessoa física)

US

Technical data

IPC Classification

Priority claims

US

62/689,530 · 06/25/2018

Abstract

São fornecidos uma combinação de poziotinibe e pelo menos um agente selecionado do grupo que consiste em agentes citotóxicos e agentes direcionados molecularmente; e um uso da combinação.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

12/20/2022

RPI 2711

Arquivamento - Art. 33 da LPI

#11.1

10/04/2022

RPI 2700

Notificação de entrada na fase nacional - PCT

#1.3

03/30/2021

RPI 2621

Alteração de dados cadastrais

#1.1

01/05/2021

RPI 2609

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.